Dates: April 18-22, 2026
Location: McCormick Place, Chicago, Illinois, USA
Organizer: American Academy of Neurology
Track: Cognitive Disorders/Dementia
Overview
The dementia track at AAN 2026 covers [Alzheimer's disease](/diseases/alzheimers-disease) and all other causes of dementia, including vascular dementia, Lewy body dementia, frontotemporal dementia, and rare causes. This comprehensive track addresses the full spectrum of cognitive disorders, from diagnosis to management and research[@aan2026].
As populations age worldwide, the burden of dementia continues to grow, making this track particularly relevant for neurologists, geriatricians, psychiatrists, and primary care providers. AAN 2026 will highlight advances in biomarkers, therapeutics, and care models for all dementia types[@niaaa].
Key Topics
Differential Diagnosis
Alzheimer's Disease
Typical and atypical presentations
Biomarker confirmation
Differential from other dementias
Vascular Dementia
Subcortical vs. cortical vascular cognitive impairment
Stroke-related cognitive decline
Mixed dementia (AD + vascular)
Lewy Body Dementia
Core and supportive features
DLB vs. [Parkinson's disease](/diseases/parkinsons-disease) dementia
Fluctuating cognition and parkinsonism
Frontotemporal Dementia
Behavioral variant FTD
Language variants: Semantic, non-fluent
FTLD spectrum disorders
...
AAN 2026 — Dementia
Dates: April 18-22, 2026
Location: McCormick Place, Chicago, Illinois, USA
Organizer: American Academy of Neurology
Track: Cognitive Disorders/Dementia
Overview
The dementia track at AAN 2026 covers [Alzheimer's disease](/diseases/alzheimers-disease) and all other causes of dementia, including vascular dementia, Lewy body dementia, frontotemporal dementia, and rare causes. This comprehensive track addresses the full spectrum of cognitive disorders, from diagnosis to management and research[@aan2026].
As populations age worldwide, the burden of dementia continues to grow, making this track particularly relevant for neurologists, geriatricians, psychiatrists, and primary care providers. AAN 2026 will highlight advances in biomarkers, therapeutics, and care models for all dementia types[@niaaa].
Key Topics
Differential Diagnosis
Alzheimer's Disease
Typical and atypical presentations
Biomarker confirmation
Differential from other dementias
Vascular Dementia
Subcortical vs. cortical vascular cognitive impairment
Stroke-related cognitive decline
Mixed dementia (AD + vascular)
Lewy Body Dementia
Core and supportive features
DLB vs. [Parkinson's disease](/diseases/parkinsons-disease) dementia
Fluctuating cognition and parkinsonism
Frontotemporal Dementia
Behavioral variant FTD
Language variants: Semantic, non-fluent
FTLD spectrum disorders
Other Dementias
Normal pressure hydrocephalus
Creutzfeldt-Jakob disease
Traumatic brain injury-related dementia
HIV-associated neurocognitive disorder
Management Approaches
Pharmacological Treatments
[Cholinesterase inhibitors](/entities/cholinesterase-inhibitors) across dementia types
[Lewy Body Dementia Association](https://www.lbda.org)
References
[American Academy of Neurology, AAN 2026 Cognitive Disorders Track (2026)](https://www.aan.com/annualmeeting)
[McKeith IG, et al., Diagnosis and management of dementia with Lewy bodies. Neurology. 2017;89:88-100 (2017)](https://pubmed.ncbi.nlm.nih.gov/28592453)
[Rascovsky K, et al., Diagnostic criteria for behavioral variant FTD. Brain. 2011;134:2456-2477 (2011)](https://pubmed.ncbi.nlm.nih.gov/21810890)
[Gorno-Tempini ML, et al., Classification of primary progressive aphasias. Brain. 2011;134:2456-2477 (2011)](https://doi.org/10.1093/brain/awq355)